Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

詳細情報 詳細情報について

• CRID

  1364233270170879360

• DOI

  10.1016/s1474-4422(10)70182-4

• ISSN

  14744422

• Web Site

  https://api.elsevier.com/content/article/PII:S1474442210701824?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1474442210701824?httpAccept=text/plain

• データソース種別

  • Crossref